NOKOMIS, Fla.--(BUSINESS WIRE)--According to a recent report from GBI Research, Strategic partnerships between pharmaceutical companies and stem cell research companies have been given a boost in stem cell R&D, and Rainbow Biosciences, a division of Rainbow Coral Corp. (OTCBB:RBCC) is positioning itself to capitalize.
